Mon, 30 Jun 2025
The phase three study data clears the path forward for Moderna's combination jab targeting Covid-19 and influenza.
>>
Terms of Use | Privacy Policy | Manage Cookies+ | Ad Choices | Accessibility & CC | About | Newsletters | Transcripts
Business News Top © 2024-2025